Skip to main content
Clinical Trials/IRCT2012073110457N1
IRCT2012073110457N1CompletedPhase 2

Clinical trial of comparison the effect of tinidazole and metronidazole tablet for treatment and recurrence of bacterial vaginosis in women of reproductive age

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran0 sites110 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
110

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 45 years (—)
Sex
Female

Inclusion Criteria

  • age 45-15 years, married women, diagnosis of bacterial vaginosis by clinical signs and diagnostic tests, accept the use of condoms during treatment. Exclusion criteria: associated with Candida vaginitis and trichomonas, Pregnancy, consume antibiotics at the same time or within two weeks and using the vaginal cream, metronidazole used simultaneously to any cause, having a chronic disease and diabetes, Immunosuppression or immune-lowering medication use, having cervicitis, chronic bacterial vaginosis

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Similar Trials